Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trans-epidermal water loss (TEWL) is the process by which water passively evaporates from the skin’s surface into the surrounding environment. It is a physiological phenomenon that occurs continuously and serves as an important indicator of skin barrier function. TEWL specifically refers to the amount of water that escapes through the stratum corneum, which is the outermost layer of the epidermis. Maintaining optimal hydration supports both appearance and function of healthy skin barriers.
N/A - TEWL is a process, not a target for drug action. Interacting substances either increase water content (humectants) or decrease water evaporation (occlusives).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trans-epidermal Water Loss (TEWL).